Clinical Trial Update: Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating cross-linked donor corneas as carriers for the Boston Keratoprosthesis has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemical Injuries
• Unspecified Complication of Corneal Transplant

Drugs mentioned

• Boston Keratoprosthesis

Snippet

Sponsor: Joseph B. Ciolino, MD | Conditions: Chemical Injuries, Unspecified Complication of Corneal Transplant | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-24